Entera Bio Shares Are Trading Higher After the Company Announced Results Showing Significant Systemic Exposure and a Favorable PK Profile in Its Obesity and Metabolic Disorder Studies.
Entera Bio Shares Are Trading Higher After the Company Announced Results Showing Significant Systemic Exposure and a Favorable PK Profile in Its Obesity and Metabolic Disorder Studies.
entara bio股價上漲,公司公佈的研究結果顯示其肥胖和代謝紊亂研究中有重要的全身暴露和有利的PK特性。
Entera Bio Shares Are Trading Higher After the Company Announced Results Showing Significant Systemic Exposure and a Favorable PK Profile in Its Obesity and Metabolic Disorder Studies.
Entera Bio的股價走高,此前該公司公佈的結果顯示其肥胖和代謝失調研究顯示出顯著的系統風險敞口和良好的Pk狀況。